Alaunos Therapeutics
TCRT
156 hedge funds and large institutions have $794M invested in Alaunos Therapeutics in 2015 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 78 increasing their positions, 19 reducing their positions, and 22 closing their positions.
311% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 19
127% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 22
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
22% more funds holding
Funds holding: 128 → 156 (+28)
8% more capital invested
Capital invested by funds: $736M → $794M (+$58.7M)
43% less call options, than puts
Call options by funds: $28.6M | Put options by funds: $50.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
+$20.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$13.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.56M |
| 5 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$4.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
-$99.4M |
| 2 |
O
OrbiMed
New York
|
-$27.3M |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$7M |
| 4 |
D.E. Shaw & Co
New York
|
-$3.39M |
| 5 |
Two Sigma Investments
New York
|
-$2.29M |
TCRT Hedge Fund Activity: Q2 2015 in Review
156 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2015, worth a combined $794M — up 8% from $736M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new TCRT positions and 22 closed out — a net gain of 28 holders — while 78 added to existing stakes and 19 trimmed.
The largest buyer was Third Point, opening a new position worth an estimated $20.2M. The largest seller was Third Security, cutting an estimated $99.4M.
- 156 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2015, up from 128 in Q1 2015.
- Funds reported $794M of Alaunos Therapeutics stock for Q2 2015, up 8% quarter-over-quarter.
- 50 funds opened new Alaunos Therapeutics positions in Q2 2015 and 22 closed out, a net change of +28 holders.
- The largest Alaunos Therapeutics buyer in Q2 2015 was Third Point, an estimated $20.2M added.
- The largest Alaunos Therapeutics seller in Q2 2015 was Third Security, an estimated $99.4M sold.
Based on aggregated 13F filings for Q2 2015.